These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

10840 related items for PubMed ID: 11215206

  • 1. [Human heparanase: roles in invasion and metastasis of cancer].
    Gohji K, Katsuoka Y, Okamoto M, Kamidono S, Kitazawa S, Toyoshima M, Dong J, Nakajima M.
    Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
    [Abstract] [Full Text] [Related]

  • 2. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA, Freeman C, Meyer-Morse N, Parish CR, Hanahan D.
    Oncogene; 2005 Jun 09; 24(25):4037-51. PubMed ID: 15806157
    [Abstract] [Full Text] [Related]

  • 3. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
    Zhao H, Liu H, Chen Y, Xin X, Li J, Hou Y, Zhang Z, Zhang X, Xie C, Geng M, Ding J.
    Cancer Res; 2006 Sep 01; 66(17):8779-87. PubMed ID: 16951194
    [Abstract] [Full Text] [Related]

  • 4. Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.
    Sanderson RD, Yang Y, Suva LJ, Kelly T.
    Matrix Biol; 2004 Oct 01; 23(6):341-52. PubMed ID: 15533755
    [Abstract] [Full Text] [Related]

  • 5. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E, Elkin M, Zcharia E, Peretz T, Vlodavsky I.
    J Natl Cancer Inst; 2004 Aug 18; 96(16):1219-30. PubMed ID: 15316057
    [Abstract] [Full Text] [Related]

  • 6. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
    Vlodavsky I, Goldshmidt O, Zcharia E, Atzmon R, Rangini-Guatta Z, Elkin M, Peretz T, Friedmann Y.
    Semin Cancer Biol; 2002 Apr 18; 12(2):121-9. PubMed ID: 12027584
    [Abstract] [Full Text] [Related]

  • 7. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
    Ilan N, Elkin M, Vlodavsky I.
    Int J Biochem Cell Biol; 2006 Apr 18; 38(12):2018-39. PubMed ID: 16901744
    [Abstract] [Full Text] [Related]

  • 8. Heparanase involvement in physiology and disease.
    Nasser NJ.
    Cell Mol Life Sci; 2008 Jun 18; 65(11):1706-15. PubMed ID: 18425416
    [Abstract] [Full Text] [Related]

  • 9. Heparanase activation induces epidermal hyperplasia, angiogenesis, lymphangiogenesis and wrinkles.
    Iriyama S, Matsunaga Y, Amano S.
    Exp Dermatol; 2010 Nov 18; 19(11):965-72. PubMed ID: 20100191
    [Abstract] [Full Text] [Related]

  • 10. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
    Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z.
    Invasion Metastasis; 1992 Nov 18; 12(2):112-27. PubMed ID: 1399400
    [Abstract] [Full Text] [Related]

  • 11. Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas.
    Mikami S, Ohashi K, Katsube K, Nemoto T, Nakajima M, Okada Y.
    Pathol Int; 2004 Aug 18; 54(8):556-63. PubMed ID: 15260846
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
    Vlodavsky I, Mohsen M, Lider O, Svahn CM, Ekre HP, Vigoda M, Ishai-Michaeli R, Peretz T.
    Invasion Metastasis; 2004 Aug 18; 14(1-6):290-302. PubMed ID: 7657522
    [Abstract] [Full Text] [Related]

  • 13. [Research advancement on heparanase in tumor metastasis].
    Li ZH, Yang SM.
    Ai Zheng; 2005 Sep 18; 24(9):1156-60. PubMed ID: 16159446
    [Abstract] [Full Text] [Related]

  • 14. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
    Vlodavsky I, Elkin M, Pappo O, Aingorn H, Atzmon R, Ishai-Michaeli R, Aviv A, Pecker I, Friedmann Y.
    Isr Med Assoc J; 2000 Jul 18; 2 Suppl():37-45. PubMed ID: 10909416
    [Abstract] [Full Text] [Related]

  • 15. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N, Disatnik MH, Nevo Z.
    J Cell Physiol; 1987 Jan 18; 130(1):77-84. PubMed ID: 3805131
    [Abstract] [Full Text] [Related]

  • 16. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
    Sanderson RD, Yang Y, Kelly T, MacLeod V, Dai Y, Theus A.
    J Cell Biochem; 2005 Dec 01; 96(5):897-905. PubMed ID: 16149080
    [Abstract] [Full Text] [Related]

  • 17. Heparanase, tissue factor, and cancer.
    Nadir Y, Vlodavsky I, Brenner B.
    Semin Thromb Hemost; 2008 Mar 01; 34(2):187-94. PubMed ID: 18645924
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanoma.
    Keren Z, Leland F, Nakajima M, LeGrue SJ.
    Cancer Res; 1989 Jan 15; 49(2):295-300. PubMed ID: 2910449
    [Abstract] [Full Text] [Related]

  • 19. Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase.
    Marchetti D, Li J, Shen R.
    Cancer Res; 2000 Sep 01; 60(17):4767-70. PubMed ID: 10987284
    [Abstract] [Full Text] [Related]

  • 20. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.
    El-Assal ON, Yamanoi A, Ono T, Kohno H, Nagasue N.
    Clin Cancer Res; 2001 May 01; 7(5):1299-305. PubMed ID: 11350898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 542.